Modulation of breast cancer resistance protein mediated atypical multidrug resistance using RNA interference delivered by adenovirus

Chinese Medical Journal

Volumn 118, Issue 13, 2005, Pages 1123-1126

  Li, Wen Tong ^a,b   Zhou, Geng Yin ^a   Wang, Chun Ling ^a   Guo, Cheng Hao ^a   Song, Xian Rang ^b   Chi, Wei Ling ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Breast cancer resistance protein; Drug resistance; RNA interference

Indexed keywords

ADENOVIRUS VECTOR; BREAST CANCER RESISTANCE PROTEIN; MESSENGER RNA; MITOXANTRONE; OLIGONUCLEOTIDE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE AMPLIFICATION; GENE CONSTRUCT; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; MODULATION; MOLECULAR CLONING; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA SEQUENCE; STATISTICAL SIGNIFICANCE; VIRAL GENE DELIVERY SYSTEM; VIRUS INFECTION; WESTERN BLOTTING;

ADENOVIRIDAE; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE SILENCING; HUMANS; MITOXANTRONE; NEOPLASM PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 21844445029     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Robey RW, Honjo V. van de Laar A, et al. A functional assay for detection of the mitoxantrone resistance protein, MXR (ABCG2). Biochim Biophys Acta 2001;1512:171-182.
2. Li WT, Zhou GY, Song XR, et al. Modulation of BCRP mediated atypical multidrug resistance phenotype by RNA interference. Neoplasma 2005;52:219-224.
3. Faneyte IF, Kristel PM, Maliepaard M, et al. Expression of the breast cancer resistance protein in breast cancer. Clin Cancer Res 2002;8:1068-1074.
4. Burger H, Foekens JA, Look MP, et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin Cancer Res 2003;9: 827-836.
5. Zhao Y, Xiao B, Chen B, et al. Upregulation of drug sensitivity of multidrug-resistant SGC7901/VCR human gastric cancer cells by bax gene transduction. Chin Med J 2000;113:977-980.
6. Rabindran SK, Ross DD, Doyle LA, et al. Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein. Cancer Res 2000;60:47-50.
7. Kowalski P, Stein U, Scheffer GL, et al. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2. Cancer Gene Ther 2002;9:579-586.
8. Tao P, Zhang J, Tang N, et al. Potent and specific inhibition of SARS-CoV antigen expression by RNA interference. Chin Med J 2005;118:714-719.
9. Yague E, Higgins CF, Raguz S. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1. Gene Ther 2004;11: 1170-1174.